NASDAQ
Enlivex Therapeutics Ltd. (ENLV) has a current ratio of 193.24x as of Monday, May 25, 2026. This represents a 1899.60% increase compared to its 12-month average of 9.66x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.